Author: openjargon

There are a lot of great ASX shares for investors to choose from on the local market.

To narrow things down for readers, let’s now take a look at two shares that analysts at Bell Potter rate very highly.

These shares feature on its favoured list for June, which the broker believes offer attractive risk-adjusted returns over the long term. They are as follows:

Regal Partners Ltd (ASX: RPL)

Bell Potter believes that this growing fund manager is being undervalued by the market.

Its analysts highlight that the company has strong organic and inorganic growth potential, strong performing investment funds, and accelerating inflows. The broker commented:

In recent years, Regal has expanded rapidly through strong investment performance, net flows into its funds, launches of new funds, and the acquisition or merger with VGI Partners, PM Capital and Taurus, which have expanded funds under management from $1.1bn in 2017, to over $12.1bn (March 2025). We continue to favour RPL, given its strong organic & inorganic growth potential, and entrepreneurial culture. In the last six months, and following the recent acquisition of PM Capital and Taurus (50%), the firm has shown an acceleration of inflows, strong investment performance (which will give rise to performance fees) and success in marketing new funds. We feel this strong performance is not reflected in the share price and see considerable upside.

Bell Potter has a buy rating and $4.02 price target on its shares. This implies potential upside of 11% for investors from current levels. A ~5.6% dividend yield is forecast over the next 12 months.

Universal Store Holdings Ltd (ASX: UNI)

Another ASX share that Bell Potter is a big fan of is Universal Store. It is a youth focused apparel, footwear and accessories retailer in Australia.

It has a large number of stores under its flagship Universal Store brand. In addition, it is expanding private label brands by growing the stand-alone format of Perfect Stranger and Thrills.

Bell Potter thinks that it has a good growth trajectory thanks to its store rollout and sees scope for margin improvements. It said:

Management execution remains a key strength for UNI and we see good growth trajectory for the name given the building of core brands while growing its store rollout. In our view, the higher margin sales from the majority of private label sales should become a major driver of margin improvement and earnings growth, in an expanded store footprint. While we remain cautious on the overall consumer sentiment, given the return to positive comps while cycling elevated pcp through Jan-Feb, we think UNI is well placed as comps become supportive through the 2H.

The broker has a buy rating and $6.15 price target on its shares. This suggests that upside of 23% is possible over the next 12 months. A ~5% dividend yield is also expected over the period.

The post Bell Potter says these ASX shares are strong buys appeared first on The Motley Fool Australia.

More reading

• Why Telstra and these excellent ASX dividend stocks could be buys
• 3 under the radar ASX shares to buy this month
• Analysts name 3 small cap ASX shares to buy for big returns
• These ASX shares could rise 25% to 65%
• 6 ASX retail shares to buy this month

Motley Fool contributor James Mickleboro has positions in Universal Store. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are searching for retirement portfolio options this month, then you may want to look at the ASX shares listed below that have been named as buys.

Here’s why these shares could be top options for this portfolio:

CSL Limited (ASX: CSL)

When you are building a retirement portfolio, it is always a smart idea to focus on high quality companies.

Well, there are arguably few higher quality businesses out there than biotechnology giant CSL. It is the company behind the CSL Behring, CSL Seqirus and CSL Vifor businesses, which provide lifesaving therapies and vaccines to patients in more than 100 countries.

And with management always reinvesting heavily in its research and development (R&D) activities, CSL consistently has an R&D pipeline filled with potentially lucrative products.

Macquarie is a fan of the company and believes its outlook is very positive thanks to its key CSL Behring business. It currently has an outperform rating and $330.00 price target on its shares. In addition, it sees scope for them to rise to $500 within the next three years.

APA Group (ASX: APA)

Another ASX share to consider buying for a retirement portfolio is APA Group. It owns and operates energy infrastructure assets and businesses.

This includes energy infrastructure, comprising gas transmission, gas storage and processing, and gas-fired and renewable energy power generation businesses.

It could be a great option for retirees due to its defensive earnings, long track record of growth (almost 20 years of dividend increase), and big dividend yield.

In respect to the latter, analysts at Macquarie are forecasting dividends of 56 cents per share in FY 2024 and 57.5 cents per share in FY 2025. Based on the current APA Group share price of $8.33, this equates to 6.7% and 6.9% dividend yields, respectively.

Macquarie currently has an outperform rating and $9.40 price target on its shares.

Woolworths Limited (ASX: WOW)

A final ASX retirement share to consider buying is supermarket giant, Woolworths. This is due to its positive growth outlook and defensive earnings.

In respect to the former, Goldman Sachs’ analysts “forecast WOW 2-yr sales CAGR FY24-26e of +3.2% and EBIT growth of +4.8%.” This is expected to support the payment of fully franked dividends of $1.08 per share in FY 2024 and $1.14 per share in FY 2025. Based on the current Woolworths share price of $32.85, this implies yields of 3.3% and 3.5%, respectively.

Goldman also sees plenty of upside for investors. It currently has a buy rating and $39.40 price target on its shares.

The post Buy these ASX shares for a winning retirement portfolio appeared first on The Motley Fool Australia.

More reading

• How much could $10,000 invested in CSL shares be worth next year?
• 3 of the best ASX 200 blue chip shares to buy now
• Tax-busters: 5 fully-franked ASX dividend shares I’d buy for FY25
• 3 reasons to be positive on ASX 200 shares in FY25 (and 3 to be wary)
• Where Aussies are spending their money, and the ASX shares that could benefit

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Apa Group and Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Now could be the time to pounce on Clinuvel Pharmaceuticals Limited (ASX: CUV) shares now if you want big returns for your portfolio.

That’s the view of analysts at Bell Potter, which are feeling very positive about the ASX 300 share.

Why is it an ASX 300 share to buy?

In case you’re not familiar with Clinuvel, it is a global specialty pharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders.

Its lead therapy is Scenesse, which is approved for commercial distribution in Europe, the USA, Israel, and Australia as the world’s first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP).

The ASX 300 share is also seeking to expand Scenesse’s use into other treatment areas. It is this that is getting Bell Potter excited. It commented:

CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with vitiligo. Following recent company announcements, we have revisited vitiligo development expectations and market forecasts. The first Phase 3 trial primary readout is expected in 2H CY25 and represents one of the next major catalysts for the company excluding financial results. Assuming the Phase 3 trials proceed smoothly, we expect submission to the FDA in late CY26 for potential approval by end-CY27.

Bell Potter notes that if successful, this expansion has the potential to be a huge boost to its sales. It adds:

With ~1% of the US population affected by vitiligo, the market size is far greater than the single rare disease for which Scenesse is currently approved. We estimate a directly addressable vitiligo market in the US of ~65-70k patients (vs. ~2k patients for EPP). This translates into legitimate potential for Scenesse to increase its annual sales several fold if the Phase 3 trials succeed and regulatory approval is granted.

Big return potential

In light of the above, the broker has reaffirmed its buy rating and $22.25 price target on the ASX 300 share. Based on its current share price of $14.60, this implies potential upside of 52% for investors over the next 12 months.

The broker concludes:

We view the first vitiligo Phase 3 readout in CY25 as a significant catalyst for the company and see the current CUV price as a good entry point for those willing to take on clinical risk with downside mitigated to a degree by the existing, profitable EPP franchise.

The post Guess which ASX 300 share could rise over 50% appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Which ASX biotech shares are pioneering the future of medicine?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The National Australia Bank Ltd (ASX: NAB) share price has increased by more than 35% in the last 12 months, as shown on the chart below. Shareholders and other investors may wonder whether the good streak can continue in FY25.

NAB has a different reporting schedule than many other ASX shares. Its full-year ends on 30 September, while June is the last month of the financial year for Australian individuals and many businesses.

There are still three and a half months left of the ASX bank share‘s FY24, so commentary about the outlook could apply to both the end of FY24 as well as FY25.

Worsening arrears

At the beginning of May 2024, NAB reported its FY24 first-half result, which showed cash earnings of $3.55 billion (down 12.8% year over year).

One of the negatives within the result was that the percentage of its loans that were overdue by at least 90 days or impaired is increasing – it was 0.66% in the FY23 first half, 0.75% in the FY23 second half and 0.79% in the first half of FY24. This represented “higher arrears across the Australian home lending and business lending portfolios, partially offset by lower impaired assets.”

NAB said:

The Australian economy is proving resilient and most customers are faring well in the current more challenging environment. However, there remains continued uncertainty in the outlook including the impacts of global instability and the ability of customers to manage the full extent of higher interest rates and elevated cost of living pressures.

Strong competition

NAB reported in the HY24 result that revenue decreased by 3.7%, mainly reflecting “lower margins”.

The net interest margin (NIM) decreased by 5 basis points (0.05%) to 1.72%, while the underlying NIM declined 10 basis points. This reflected “lending margin competitive pressures primarily relating to housing lending, along with higher term deposit costs and deposit mix impacts.”

NAB said the benefits of a higher interest rate environment have been more than offset by competition while cost pressures remain elevated.

NAB shares its outlook

With the FY24 first-half result, the ASX bank share said the following:

With our new executive leadership team in place, we are considering how we evolve our strategic priorities. We start in a great place with strong, safe balance sheet settings and attractive growth options. While no major strategic pivots are needed, we are excited about opportunities to leverage the good work of the past several years to allow us to become even simpler and drive better outcomes for customers and colleagues while maintaining a disciplined approach. This will remain at the core of everything we do and underpin our ability to deliver sustainable growth and returns.

Forecasts

Analysts at broker UBS expect stronger results in FY25 than in FY24.

The broker currently forecasts that NAB could generate net profit after tax (NPAT) of $7 billion in FY24 and $7.15 billion in FY25. This would translate into earnings per share (EPS) of $2.21 in FY24 and $2.27 in FY25. While higher, this does not imply much growth in FY25.

UBS expects NAB shares to offer a fully franked dividend yield of around 5% over the next two financial years.

The broker currently has a sell on NAB shares because of a “fully valued” NAB share price. The price target is $30, implying a fall of 15% from where it is today.

The post Can owners of NAB shares bank on a good outlook for FY25? appeared first on The Motley Fool Australia.

More reading

• Up 39% in a year, the NAB share price just hit a 9-year high!
• Big bank bargain: Are this week’s tumbling ASX 200 bank shares a good buy?
• Are ASX 200 bank shares a good investment right now?
• Forget NAB and buy these ASX dividend shares
• Here’s the average wealth of Aussies who manage their own superannuation

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The great news for growth investors is that there are plenty of quality options to choose from on the Australian share market.

But which ones could be buys in June?

Let’s take a look at five ASX growth shares that brokers rate highly:

Domino’s Pizza Enterprises Ltd (ASX: DMP)

This pizza chain operator has been struggling in recent years due to operational mishaps and inflationary pressures. While this is disappointing, there are signs that the worst could now be over and its fortunes could improve from FY 2025.

Morgan Stanley appears to believe this makes it a good time to make a patient investment in Domino’s. Last month, it put an overweight rating and $52.00 price target on its shares.

IPD Group Ltd (ASX: IPG)

Analysts at Bell Potter think that this distributor of electrical equipment and industrial digital technologies could be an ASX growth share to buy in June.

Its analysts expect the company to benefit from the electrification megatrend. They note that IPG is “a high quality play on the electrification growth trend which is emerging as a dominant market narrative.”

Bell Potter has the company on its preferred list with a buy rating and $5.60 price target.

Lovisa Holdings Ltd (ASX: LOV)

The team at Morgans is feeling very positive about Lovisa and sees it as an ASX growth share to buy this month.

It believes the growing fashion jewellery retailer is well-positioned to continue its strong form long into the future thanks to its large global expansion opportunity. It has previously noted that its plan to “enter mainland China in FY24, [is] paving the way for significant longer-term growth.” This expansion has since taken place and has started positively according to industry date.

Morgans currently has an add rating and $35.00 price target on its shares.

Treasury Wine Estates Ltd (ASX: TWE)

Morgans also thinks that Treasury Wine could be an ASX growth share to buy right now. This is partly due to its recent acquisition of DAOU Vineyards (DAOU) for US$900 million (A$1.4 billion).

The broker notes that “if TWE delivers on its investment case, there is material upside to our valuation.”

Morgans has an add rating and $14.03 price target on its shares.

Webjet Limited (ASX: WEB)

Finally, the team at Morgans is also bullish on online travel booking company Webjet.

It thinks Webjet could be an ASX growth share to buy thanks largely to its dominant WebBeds B2B business and the “significant market share still up for grabs.” Morgans believes this positions the company well for the future.

The broker has an add rating and price target of $11.20 on Webjet’s shares.

The post 5 top ASX growth shares to buy in June appeared first on The Motley Fool Australia.

More reading

• 2 ‘pick and shovel’ ASX stocks to cash in on the AI megatrend
• Top ASX AI stocks to buy in June 2024
• Is Guzman y Gomez stock too expensive?
• 3 under the radar ASX shares to buy this month
• Is this ASX small-cap stock an overlooked beneficiary of the AI boom?

Motley Fool contributor James Mickleboro has positions in Domino’s Pizza Enterprises, Lovisa, and Treasury Wine Estates. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza Enterprises, Ipd Group, and Lovisa. The Motley Fool Australia has positions in and has recommended Ipd Group. The Motley Fool Australia has recommended Domino’s Pizza Enterprises, Lovisa, and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.